{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:42:57Z","timestamp":1786203777576,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00520-026-11065-3","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T05:21:57Z","timestamp":1785561717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psilocybin for Fear of Cancer Recurrence"],"prefix":"10.1007","volume":"34","author":[{"given":"Matthew","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hapke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"issue":"12","key":"11065_CR1","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1016\/S1470-2045(25)00530-3","volume":"26","author":"G Rodin","year":"2025","unstructured":"Rodin G, Feldman A, Trapani D, Skelton M, Unger-Salda\u00f1a K, Essue B et al (2025) The human crisis in cancer: a Lancet Oncology Commission. Lancet Oncol 26(12):e628\u2013e670. https:\/\/doi.org\/10.1016\/S1470-2045(25)00530-3","journal-title":"Lancet Oncol"},{"issue":"6","key":"11065_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/pon.5921","volume":"31","author":"YL Luigjes-Huizer","year":"2022","unstructured":"Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WWT, Lebel S et al (2022) What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology 31(6):879\u2013892. https:\/\/doi.org\/10.1002\/pon.5921","journal-title":"Psychooncology"},{"issue":"2","key":"11065_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/pon.5283","volume":"29","author":"B Mutsaers","year":"2020","unstructured":"Mutsaers B, Butow P, Dinkel A, Humphris G, Maheu C, Ozakinci G, Prins J, Sharpe L, Smith AB, Thewes B, Lebel S (2020) Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psychooncology 29(2):430\u2013436. https:\/\/doi.org\/10.1002\/pon.5283","journal-title":"Psychooncology"},{"key":"11065_CR4","doi-asserted-by":"publisher","unstructured":"Butow PN, Sharpe L, Thewes B (2021) Fear of cancer recurrence. In: Breitbart W, Butow PN, Jacobsen PB, Lam WWT, Lazenby M, Loscalzo M, editors. Psycho-Oncology. 4th ed. Oxford University Press. https:\/\/doi.org\/10.1093\/med\/9780190097653.003.0094","DOI":"10.1093\/med\/9780190097653.003.0094"},{"key":"11065_CR5","doi-asserted-by":"publisher","first-page":"1575813","DOI":"10.3389\/fonc.2025.1575813","volume":"15","author":"R Aguiar-Ib\u00e1\u00f1ez","year":"2025","unstructured":"Aguiar-Ib\u00e1\u00f1ez R, Mbous YPV, Sharma S, Chawla E, Pawar D (2025) Clinical, humanistic and economic burden associated with recurrence among patients with early-stage cancers: a systematic literature review. Front Oncol 15:1575813. https:\/\/doi.org\/10.3389\/fonc.2025.1575813","journal-title":"Front Oncol"},{"key":"11065_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2147\/PRBM.S231577","volume":"13","author":"AB Smith","year":"2020","unstructured":"Smith AB, Costa D, Galica J, Lebel S, Tauber N, van Helmondt SJ, Zachariae R (2020) Spotlight on the fear of cancer recurrence inventory (FCRI). Psychol Res Behav Manag 13:1257\u20131268. https:\/\/doi.org\/10.2147\/PRBM.S231577","journal-title":"Psychol Res Behav Manag"},{"issue":"6","key":"11065_CR7","doi-asserted-by":"publisher","first-page":"e6364","DOI":"10.1002\/pon.6364","volume":"33","author":"L Gigu\u00e8re","year":"2024","unstructured":"Gigu\u00e8re L, Mutsaers B, Harris C, Smith AB, Humphris GM, Costa D et al (2024) The Ottawa clinical fear of recurrence instruments: a screener, self-report, and clinical interview. Psychooncology 33(6):e6364. https:\/\/doi.org\/10.1002\/pon.6364","journal-title":"Psychooncology"},{"issue":"10","key":"11065_CR8","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1177\/1359105315576352","volume":"21","author":"DM Posluszny","year":"2010","unstructured":"Posluszny DM, Dew MA, Beckjord E, Bovbjerg DH, Schmidt JE, Low CA et al (2010) Existential challenges experienced by lymphoma survivors: results from the 2010 LIVESTRONG survey. J Health Psychol 21(10):2357\u20132366. https:\/\/doi.org\/10.1177\/1359105315576352","journal-title":"J Health Psychol"},{"issue":"12","key":"11065_CR9","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1007\/s00520-020-05434-9","volume":"28","author":"C Borreani","year":"2020","unstructured":"Borreani C, Alfieri S, Farina L, Bianchi E, Corradini P (2020) Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors. Support Care Cancer 28(12):5973\u20135982. https:\/\/doi.org\/10.1007\/s00520-020-05434-9","journal-title":"Support Care Cancer"},{"key":"11065_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12885-021-08909-y","volume":"22","author":"SY Park","year":"2022","unstructured":"Park SY, Lim JW (2022) Cognitive behavioral therapy for reducing fear of cancer recurrence (FCR) among breast cancer survivors: a systematic review of the literature. BMC Cancer 22:217. https:\/\/doi.org\/10.1186\/s12885-021-08909-y","journal-title":"BMC Cancer"},{"issue":"31","key":"11065_CR11","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1200\/JCO.19.00572","volume":"37","author":"NM Tauber","year":"2019","unstructured":"Tauber NM, O\u2019Toole MS, Dinkel A, Galica J, Humphris G, Lebel S et al (2019) Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol 37(31):2899\u20132915. https:\/\/doi.org\/10.1200\/JCO.19.00572","journal-title":"J Clin Oncol"},{"issue":"16","key":"11065_CR12","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1002\/cncr.35326","volume":"130","author":"DL Hall","year":"2024","unstructured":"Hall DL, Wagner LI, Lebel S, Smith AB, Bergerot CD, Park ER (2024) Guidelines needed for the management of fear of cancer recurrence in adult survivors of cancer in the United States: a consensus statement. Cancer 130(16):2739\u20132742. https:\/\/doi.org\/10.1002\/cncr.35326","journal-title":"Cancer"},{"key":"11065_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015383.pub2","author":"S Schipper","year":"2024","unstructured":"Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y et al (2024) Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD015383.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"11065_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/nursrep14010024","volume":"14","author":"A Londoudi","year":"2024","unstructured":"Londoudi A, Skampardonis K, Alikari V, Prapa PM, Toska A, Saridi M et al (2024) Assessment of the relationship between fear of cancer recurrence, spiritual well-being, and mental health among cancer patients: a cross-sectional study. Nurs Rep 14(1):317\u2013327. https:\/\/doi.org\/10.3390\/nursrep14010024","journal-title":"Nurs Rep"},{"issue":"5","key":"11065_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/0022167817715966","volume":"57","author":"TC Swift","year":"2017","unstructured":"Swift TC, Belser AB, Agin-Liebes G, Devenot N, Terrana S, Friedman HL et al (2017) Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. J Hum Psychol 57(5):488\u2013519. https:\/\/doi.org\/10.1177\/0022167817715966","journal-title":"J Hum Psychol"},{"key":"11065_CR16","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.jpainsymman.2026.03.012","volume":"72","author":"ACM Garcia","year":"2026","unstructured":"Garcia ACM, Isidoro GM, Silva CP (2026) Psychedelic experiences and finitude in serious illness: a qualitative synthesis. J Pain Symptom Manage 72:e10\u2013e34. https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.03.012","journal-title":"J Pain Symptom Manage"},{"key":"11065_CR17","doi-asserted-by":"publisher","first-page":"109174","DOI":"10.1016\/j.neuropharm.2022.109174","volume":"216","author":"S Ross","year":"2022","unstructured":"Ross S, Agrawal M, Griffiths RR, Grob C, Berger A, Henningfield JE (2022) Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care. Neuropharmacology 216:109174. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109174","journal-title":"Neuropharmacology"},{"key":"11065_CR18","unstructured":"Fischer S (2024) Study of psilocybin assisted psychotherapy to address fear of recurrence [Internet]. ClinicalTrials.gov. Identifier NCT06430541. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06430541"},{"issue":"10","key":"11065_CR19","doi-asserted-by":"publisher","first-page":"e0293349","DOI":"10.1371\/journal.pone.0293349","volume":"18","author":"J Evans","year":"2023","unstructured":"Evans J, Robinson OC, Argyri EK, Suseelan S, Murphy-Beiner A, McAlpine R, Luke D, Michelle K, Prideaux E (2023) Extended difficulties following the use of psychedelic drugs: a mixed methods study. PLoS ONE 18(10):e0293349. https:\/\/doi.org\/10.1371\/journal.pone.0293349","journal-title":"PLoS ONE"},{"issue":"12","key":"11065_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2024.2546","volume":"81","author":"JT Hinkle","year":"2024","unstructured":"Hinkle JT, Graziosi M, Nayak SM, Yaden DB (2024) Adverse events in studies of classic psychedelics: a systematic review and meta-analysis. JAMA Psychiat 81(12):1225\u20131235. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.2546","journal-title":"JAMA Psychiat"},{"key":"11065_CR21","unstructured":"Lebel S, Zwaal C, Craig L, Conrod R, Freeman L, Galica J, Maheu C, Nissim R, Savard J, et al (2024) Fear of cancer recurrence guideline. Toronto (ON): Ontario Health (Cancer Care Ontario). Program in Evidence-Based Care Guideline No.: 19\u20137"},{"issue":"9","key":"11065_CR22","doi-asserted-by":"publisher","first-page":"e1004519","DOI":"10.1371\/journal.pmed.1004519","volume":"22","author":"BR Lewis","year":"2025","unstructured":"Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL (2025) Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: a randomized controlled trial. PLoS Med 22(9):e1004519. https:\/\/doi.org\/10.1371\/journal.pmed.1004519","journal-title":"PLoS Med"},{"issue":"12","key":"11065_CR23","doi-asserted-by":"publisher","first-page":"e2449026","DOI":"10.1001\/jamanetworkopen.2024.49026","volume":"7","author":"AL Back","year":"2024","unstructured":"Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S et al (2024) Psilocybin therapy for clinicians with symptoms of depression from frontline care during the COVID-19 pandemic: a randomized clinical trial. JAMA Netw Open 7(12):e2449026. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.49026","journal-title":"JAMA Netw Open"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11065-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11065-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11065-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:55:53Z","timestamp":1786200953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11065-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11065"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11065-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"819"}}